Đang chuẩn bị liên kết để tải về tài liệu:
Báo cáo y học: "Pro/con debate: Should antimicrobial stewardship programs be adopted universally in the intensive care unit"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học quốc tế cung cấp cho các bạn kiến thức về ngành y đề tài: Pro/con debate: Should antimicrobial stewardship programs be adopted universally in the intensive care unit? | George and Morris Critical Care 2010 14 205 http ccforum.eom content 14 1 205 CRITICAL CARE REVIEW L_ Pro con debate Should antimicrobial stewardship programs be adopted universally in the intensive care unit Philip George1 and Andrew M Morris2 Abstract You are director of a large multi-disciplinary ICU. You have recently read that hospital-wide antibiotic stewardship programs have the potential to improve the quality and safety of care and to reduce the emergence of multi-drug resistant organisms and overall costs. You are considering starting one of these programs in your ICU but are concerned about the associated infrastructure costs. You are debating whether it is worth bringing the concept forward to your hospital s administration to consider investing in. Statement for debate Antibiotic stewardship programs improve patient outcomes and cost-effectiveness in critically ill patients in the ICU. Introduction Antibiotic stewardship programs are multidisciplinary initiatives whose primary aim is to optimize antibiotic usage. The Infectious Disease Society of America IDSA and the Society for Health Care Epidemiology of America SHEA published guidelines for antimicrobial stewardship in 2007 aimed at providing information on how to establish such programs within health care institutions 1 . Because antibiotics are used heavily in the ICU stewardship programs appear particularly applicable to this setting. Antimicrobial stewardship is broadly defined as a practice that ensures the optimal selection dose and duration of antimicrobials and leads to the best clinical outcome for the treatment or prevention of infection Correspondence amorris@mtsinai.on.ca 2Division of Infectious Diseases Department of Medicine Mount Sinai Hospital and University Health Network Mount Sinai Hospital 600 University Avenue Suite 415 Toronto ON M5G 1X5 Canada Full list of author information is available at the end of the article 2 BioMed Central 2010 BioMed Central Ltd while producing .